This report contains market size and forecasts of Cancer Genomic Testing in Global, including the following market information:
Global Cancer Genomic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Genomic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Breast Cancer Genomic Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Genomic Testing include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience and Bio-Rad Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Genomic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genomic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genomic Testing Market Segment Percentages, by Type, 2021 (%)
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Global Cancer Genomic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genomic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
Global Cancer Genomic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Genomic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genomic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Genomic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific